Cap with an extension, particularly for a dust cap of a metered dose inhaler
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
FIG. 1 is a front perspective view of a first cap with an extension, as shown and described;
FIG. 2 is a rear view of the cap shown in FIG. 1;
FIG. 3 is an underneath plan view of the cap shown in FIG. 1;
FIG. 4 is a front view of the cap shown in FIG. 1;
FIG. 5 is a plan view of the cap shown in FIG. 1;
FIG. 6 is a side view of the cap shown in FIG. 1;
FIG. 7 is a front perspective view of a second cap with an extension, as shown and described;
FIG. 8 is a rear view of the cap shown in FIG. 7;
FIG. 9 is an underneath plan view of the cap shown in FIG. 7;
FIG. 10 is a front view of the cap shown in FIG. 7;
FIG. 11 is a plan view of the cap shown in FIG. 7; and,
FIG. 12 is a side view of the cap shown in FIG. 7.
Claims
The ornamental design for a cap with an extension, particularly for a dust cap of a metered dose inhaler, as shown and described.
Type: Grant
Filed: Mar 11, 2005
Date of Patent: Mar 6, 2007
Assignee: Glaxo Group Limited (Greenford)
Inventors: Mark Anthony Cox (Ware), Allen John Pearson (Huntingdon), Paul Kenneth Rand (Ware)
Primary Examiner: Antoine D. Davis
Assistant Examiner: Christopher Lee
Attorney: James P. Riek
Application Number: 29/225,112